Author

J.-Y. Min

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

M. Ko· 2 shared A. Ianevski· 1 shared A. L. P. H. d'Alexandry d'Orengiani· 1 shared D. Kainov· 1 shared D. Shum· 1 shared H. Kim· 1 shared I. Choi· 1 shared J. Chung· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. Ko

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19

M. Ko, S. Y. Chang, S. Y. Byun, A. Ianevski, I. Choi, A. L. P. H. d'Alexandry d'Orengiani, D. Kainov, D. Shum, J.-Y. Min, M. P. Windisch

The paper screens FDA-approved drugs against a MERS-CoV isolate to identify potential therapies for COVID-19, finding several drugs with therapeutic indexes >6 and synergistic combinations.

bioRxiv · Feb 25, 2020Microbiology

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus

K. H. Kim, J. Kim, M. Ko, J. Y. Chun, H. Kim, S. Kim, J.-Y. Min, W. B. Park, M.-d. Oh, J. Chung

This paper isolates an antibody from a recovered SFTS patient that inhibits multiple SFTSV strains and protects mice from infection, suggesting its potential as a therapeutic agent.

bioRxiv · Oct 3, 2018Biochemistry